Pallarés HM, González López Ledesma MM, Oviedo-Rouco S, Castellano LA, Costa Navarro GS, Fernández-Alvarez AJ, D'Andreiz MJ, Aldas-Bulos VD, Alvarez DE, Bazzini AA, Gamarnik AV. Zika virus non-coding RNAs antagonize antiviral responses by PKR-mediated translational arrest. Nucleic Acids Research 2024 Jun 25:gkae507. doi: https://doi.org/10.1093/nar/gkae507 Pubmed
Bottero D, Rudi E, Martin Aispuro P, Zurita E, Gaillard E, Gonzalez Lopez Ledesma MM, Malito J, Stuible M, Ambrosis N, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron. Frontiers in Immunology. Nov 10;14:1271209. (2023) doi: 10.3389/fimmu.2023.1271209. PubMed
Giai C, Salassa BN, Zarelli VE, Bello OD, Vanrell MC, Ojeda DS, Gamarnik A, Colombo MI. Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2. Heliyon. 9(5):e15211 (2023). doi: 10.1016/j.heliyon.2023.e15211. PubMed
Gonzalez Lopez Ledesma MM, Costa Navarro G, Pallares HM, Paletta A, De Maio F, Iglesias NG, Gebhard L, Oviedo Rouco S, Ojeda DS, de Borba L, Giraldo M, Rajsbaum R, Ceballos A, Krogan NJ, Shah PS, Gamarnik AV. Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation. Proc Natl Acad Sci U S A. 120(23):e2220005120 (2023). doi: 10.1073/pnas.2220005120. PubMed
Adler NS, Cababie LA, Sarto C, Cavasotto CN, Gebhard LG, Estrin DA, Gamarnik AV, Arrar M, Kaufman SB. Insights into the product release mechanism of dengue virus NS3 helicase. Nucleic Acids Res. 50(12):6968-6979 (2022). doi: 10.1093/nar/gkac473. PubMed
Gabriel MV, Sallaberry I, Costa Navarro GS, Gratton E, Gamarnik AV, Estrada LC. Dengue Virus Capsid-Protein Dynamics in Live Infected Cells Studied by Pair Correlation Analysis. Methods Mol Biol. 2409:99-117 (2022). doi: 10.1007/978-1-0716-1879-0_8. PubMed
Gonzalez Lopez Ledesma MM, Sanchez L, Ojeda DS, Oviedo Rouco S, Rossi AH, Varese A, Mazzitelli I, Pascuale CA, Miglietta EA, Rodríguez PE, Pallarés HM, Costa Navarro GS, Caramelo JJ, Rothlauf PW, Liu Z, Bloyet LM, Cornejo Pontelli M, Rasetto NB, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Bianchimano L, Ríos AS, Treffinger Cienfuegos MS, Rodriguez García DR, Longueira Y, Laufer N, Alvarez D, Ceballos A, Ochoa V, Monzani C, Turk G, Salvatori M, Carradori J, Prost K, Rima A, Varela C, Ercole R, Toro RI, Gutierrez S, Zubieta M, Acuña D, Nabaes Jodar MS, Torres C, Mojsiejczuk L, Viegas M, Velazquez P, Testa C, Kreplak N, Yanovsky M, Whelan S, Geffner J, Pifano M, Gamarnik AV. Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time. mBio. 13(1):e0344221 (2022). doi: 10.1128/mbio.03442-21. PubMed
Longueira Y, Ojeda DS, Battistelli RBA, Sanchez L, Oviedo Rouco S, Albano D, Guevara E, Valls V, Pando MA, Gamarnik AV. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants. Front Immunol. 13:909995 (2022). doi: 10.3389/fimmu.2022.909995. PubMed
Pascuale CA, Varese A, Ojeda DS, Pasinovich ME, Lopez L, Rossi AH, Rodriguez PE, Miglietta EA; Laboratorio SeVa Group, Mazzitelli I, Di Diego Garcia F, Sanchez L, Rouco SO, Gonzalez Lopez Ledesma MM, Zurano JP, Mazzitelli B, Scruzzi G, Barbero P, Cardozo D, Gallego S, Borda M, Diaz M; Ministerio de Salud de la Provincia de Córdoba Group; UNC-Fac. Cs. Médicas-InViV Group, Ridao F, Rosales AB; Ministerio de Salud de la Provincia de La Rioja Group, Bhon J, Talia JM, Diangelo ME, Lacaze MA; Ministerio de Salud de la Provincia de San Luis Group, Aime B, Gutierrez SI, Ercole R, Toro R, Tau L, Delaplace L, Compagnucci MF; Universidad Nacional de La Plata Group, Sartori C, Desimone I, Echegoyen C, Velazquez P, Testa C; Ministerio de Salud de la Provincia de Buenos Aires Group, Hozbor D, Docena G, Laino CH, Kreplak N, Pifano M, Barbas G, Rearte A, Vizzotti C, Castelli JM, Geffner J, Gamarnik AV. Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273. Cell Rep Med. 3(8):100706 (2022). doi: 10.1016/j.xcrm.2022.100706. PubMed
Pecora A, Malacari DA, Mozgovoj MV, Díaz MLA, Peralta AV, Cacciabue M, Puebla AF, Carusso C, Mundo SL, Gonzalez Lopez Ledesma MM, Gamarnik AV, Rinaldi O, Vidal O, Mas J, Dus Santos MJ. Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires. Front Vet Sci. 9:790058 (2022). doi: 10.3389/fvets.2022.790058. PubMed
Rodriguez PE, Silva AP, Miglietta EA, Rall P, Pascuale CA, Ballejo C, López Miranda L, Ríos AS, Ramis L, Marro J, Poncet V, Mazzitelli B, Salvatori M, Ceballos A, Gonzalez Lopez Ledesma MM, Ojeda DS, Aguirre MF, Miragaya Y, Gamarnik AV, Rossi AH; Laboratorio SeVa Group; PAMI Group. Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina. Front Immunol. 13:992370 (2022). doi: 10.3389/fimmu.2022.992370. PubMed Brief Report
Rouco SO, Rodriguez PE, Miglietta EA, Rall P, Ledesma MMGL, Varese A, Pascuale CA, Ojeda DS, Mazzitelli B, Sanchez L, Ceballos A, Perez E, Geffner J, Miragaya Y, Rossi AH, Gamarnik AV. Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people. Lancet Infect Dis. 22(8):1118-1119 (2022). doi: 10.1016/S1473-3099(22)00427-3. PubMed Letter
Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern. Front Immunol. 13:1020159 (2022). doi: 10.3389/fimmu.2022.1020159. PubMed
Sanchez L, Oviedo Rouco S, Pifano M, Ojeda DS, Pascuale CA, Mazzitelli B, Di Diego Garcia F, Gonzalez Lopez Ledesma MM, Rodriguez PE, Miglietta EA, Ceballos A, Rossi AH, Kreplak N, Geffner J, Gamarnik AV. Antibody durability at 1 year after Sputnik V vaccination. Lancet Infect Dis. 22(5):589-590 (2022). doi: 10.1016/S1473-3099(22)00176-1. PubMed Letter
Varese A, Mazzitelli B, Díaz FE, Kjolhede MV, Ojeda D, Vellicce A, Arto P, Cicero C, Pascowski M, Figueras L, Broese B, Dávila R, Zarlenga R, Rivelli F, Verruno C, Silenzi V, Beltrán I, Gamarnik A, Ceballos A, Zala C, Badolati A, Geffner J. Omicron breakthrough infection after heterologous prime-boost vaccination induces a vigorous antibody response. J Infect Dis. 226(10):1717-1720 (2022). doi: 10.1093/infdis/jiac250. PubMed Brief Report